[go: up one dir, main page]

NO20020676D0 - Oral administreringsform som inneholder probiotiske mikroorganismer - Google Patents

Oral administreringsform som inneholder probiotiske mikroorganismer

Info

Publication number
NO20020676D0
NO20020676D0 NO20020676A NO20020676A NO20020676D0 NO 20020676 D0 NO20020676 D0 NO 20020676D0 NO 20020676 A NO20020676 A NO 20020676A NO 20020676 A NO20020676 A NO 20020676A NO 20020676 D0 NO20020676 D0 NO 20020676D0
Authority
NO
Norway
Prior art keywords
oral administration
probiotic microorganisms
administration containing
containing probiotic
microorganisms
Prior art date
Application number
NO20020676A
Other languages
English (en)
Other versions
NO20020676L (no
Inventor
Joachim Bug
Iris Manneck
Martina Schmid
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020676L publication Critical patent/NO20020676L/no
Publication of NO20020676D0 publication Critical patent/NO20020676D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020676A 1999-08-12 2002-02-11 Oral administreringsform som inneholder probiotiske mikroorganismer NO20020676D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937361A DE19937361A1 (de) 1999-08-12 1999-08-12 Orale Darreichungsform
PCT/EP2000/006580 WO2001012164A1 (de) 1999-08-12 2000-07-12 Orale darreichungsform enthaltend probiotische mikroorganismen

Publications (2)

Publication Number Publication Date
NO20020676L NO20020676L (no) 2002-02-11
NO20020676D0 true NO20020676D0 (no) 2002-02-11

Family

ID=7917589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020676A NO20020676D0 (no) 1999-08-12 2002-02-11 Oral administreringsform som inneholder probiotiske mikroorganismer

Country Status (20)

Country Link
EP (1) EP1207859B1 (no)
JP (1) JP2003506481A (no)
KR (1) KR20020031383A (no)
CN (1) CN1364076A (no)
AR (1) AR025020A1 (no)
AT (1) ATE276746T1 (no)
AU (1) AU770792B2 (no)
BR (1) BR0013110A (no)
CA (1) CA2377415A1 (no)
CZ (1) CZ2002354A3 (no)
DE (2) DE19937361A1 (no)
HK (1) HK1048065A1 (no)
HU (1) HUP0203029A3 (no)
MX (1) MXPA02000630A (no)
NO (1) NO20020676D0 (no)
PL (1) PL353878A1 (no)
RU (1) RU2002105484A (no)
SK (1) SK1632002A3 (no)
WO (1) WO2001012164A1 (no)
ZA (1) ZA200110534B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE10206995B4 (de) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
ES2368344T3 (es) 2005-05-18 2011-11-16 Dsm Ip Assets B.V. Composiciones para aplicación parenteral de microorganismos.
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
DE202007013316U1 (de) 2007-09-21 2009-02-12 Voss Automotive Gmbh Anschlussvorrichtung für Medienleitungen
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2808610C (en) 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
JP2014189547A (ja) * 2013-03-28 2014-10-06 Lintec Corp 嚥下物被覆体
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP2018528938A (ja) * 2015-08-31 2018-10-04 ネステク ソシエテ アノニム 情動的反応を制御するため、並びに潜在的な気分変調の治療及び予防のための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
CN107115311A (zh) * 2017-05-04 2017-09-01 江苏大学 一种双歧杆菌肠溶片及其制备方法
JP2023510158A (ja) * 2019-12-27 2023-03-13 エヴェロ バイオサイエンシズ，インコーポレーテッド 細菌及び微生物細胞外小胞を含有する固形剤形
CN115551486A (zh) * 2020-04-17 2022-12-30 伊夫罗生物科学公司 具有改善的崩解谱的固体剂型
US11426353B2 (en) * 2020-06-24 2022-08-30 13400719 Canada Inc. Composite coating for an active agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
JP3083169B2 (ja) * 1991-02-27 2000-09-04 日清製粉株式会社 ビフィズス菌製剤およびその製法
JP3187502B2 (ja) * 1992-01-09 2001-07-11 カネボウ株式会社 腸溶性造粒物
JP2859217B2 (ja) * 1995-08-10 1999-02-17 日清製粉株式会社 腸内有用細菌含有顆粒の製造方法
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
JPH11139978A (ja) * 1997-11-06 1999-05-25 Asahi Beer Yakuhin Kk 腸溶性生菌製剤

Also Published As

Publication number Publication date
EP1207859B1 (de) 2004-09-22
HUP0203029A3 (en) 2004-10-28
DE19937361A1 (de) 2001-02-22
NO20020676L (no) 2002-02-11
RU2002105484A (ru) 2003-11-20
JP2003506481A (ja) 2003-02-18
MXPA02000630A (es) 2002-08-30
ZA200110534B (en) 2003-07-30
KR20020031383A (ko) 2002-05-01
CN1364076A (zh) 2002-08-14
CZ2002354A3 (cs) 2002-05-15
AU6158100A (en) 2001-03-13
CA2377415A1 (en) 2001-02-22
EP1207859A1 (de) 2002-05-29
SK1632002A3 (en) 2002-06-04
AR025020A1 (es) 2002-11-06
AU770792B2 (en) 2004-03-04
ATE276746T1 (de) 2004-10-15
WO2001012164A1 (de) 2001-02-22
PL353878A1 (en) 2003-12-01
DE50007927D1 (de) 2004-10-28
HK1048065A1 (zh) 2003-03-21
BR0013110A (pt) 2002-05-07
HUP0203029A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20020676L (no) Oral administreringsform som inneholder probiotiske mikroorganismer
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
ZA200202480B (en) Oral dosage forms.
HUP0203204A3 (en) Oral dosage forms
AU1998200A (en) Multiparticulate oral dosage forms
IS6263A (is) Lyfjasamsetningar, sem innihalda trípeptíð
FI991485A0 (fi) Uusi farmaseuttinen koostumus
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
MXPA03004941A (es) Formulacion farmacologica que tiene tolerancia por via oral mejorada.
AU4024100A (en) Anti-caries oral care compositions
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
AU2001259693A1 (en) Oral devices
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
EP1187622A4 (en) STERILIZATION TECHNIQUE
PT1210119E (pt) Composicoes farmaceuticas para administracao oral e topica
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
ID30397A (id) Larutan oral prukaloprida
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
GB9923045D0 (en) New oral formulations
EP1224867A4 (en) BIFIDOBACTERIUM-CONTAINING FERMENTED FOOD
HUP0201914A3 (en) Oral care composition
ZA200108206B (en) Oral pharmaceutical ibuprofen suspension.
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application